![TFD [LOGO].png](https://static.wixstatic.com/media/1c4fd3_548a902f0e634d898458c2078da13fc9~mv2.png/v1/crop/x_67,y_226,w_358,h_43/fill/w_169,h_20,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/TFD%20%5BLOGO%5D.png){kind=small}
![TFD [LOGO] (10).png](https://static.wixstatic.com/media/bea252_c1775b2fb69c4411abe5f0d27e15b130~mv2.png/v1/crop/x_150,y_143,w_1221,h_1193/fill/w_179,h_176,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/TFD%20%5BLOGO%5D%20(10).png)
A clinical trial for a novel coronavirus vaccine got underway at UC Davis Health in Sacramento on Thursday.
Pfizer picked Sacramento as one of 120 sites to be a part of the worldwide COVID-19 trial. The company aims to enroll about 30,000 participants from across the globe, according to KCRA 3 News.
Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
UC Davis said it needs more volunteers for the vaccine trial. Participants could earn $700.
